Modified Alginates for Islet Encapsulation and Diabetes Treatment
Exclusively Licensed
Invention type: Technology
/
Case number: #14528JQ
Covalently modified alginate polymers, possessing enhanced biocompatibility and tailored physiochemical properties, as well as methods of making and use thereof, are disclosed herein. The covalently modified alginates are useful as a matrix for the encapsulation and transplantation of cells. Also disclosed are high throughput methods for the characterizing the biocompatibility and physiochemical properties of modified alginate polymers.
Researchers
Robert Langer
/
Arturo Vegas
/
Kaitlin Bratlie
/
Minglin Ma
/
Daniel Anderson
Departments: Office of the Institute Professors, Department of Chemical Engineering
Technology Areas: Biotechnology: Tissue Engineering / Chemicals & Materials: Catalysis & Synthesis, Polymers / Therapeutics: Cell Based Therapy
Impact Areas: Healthy Living, Advanced Materials
-
modified alginates for cell encapsulation and cell therapy
United States of America | Granted | 11,337,930 -
modified alginates for cell encapsulation and cell therapy
United States of America | Granted | 9,422,373 -
modified alginates for cell encapsulation and cell therapy
Canada | Granted | 2,837,558 -
modified alginates for islet encapsulation and diabetes treatment
European Patent Convention | Granted | 2,714,747 -
modified alginates for cell encapsulation and cell therapy
United States of America | Granted | 10,285,949 -
modified alginates for cell encapsulation and cell therapy
European Patent Convention | Granted | 3,354,665 -
modified alginates for cell encapsulation and cell therapy
United States of America | Granted | 10,292,936 -
modified alginates for cell encapsulation and cell therapy
United States of America | Granted | 10,842,753 -
modified alginates for cell encapsulation and cell therapy
Hong Kong | Granted | 1,259,279 -
modified alginates for cell encapsulation and cell therapy
European Patent Convention | Published application -
modified alginates for cell encapsulation and cell therapy
Austria | Granted | 3,354,665 -
modified alginates for cell encapsulation and cell therapy
Belgium | Granted | 3,354,665 -
modified alginates for cell encapsulation and cell therapy
Denmark | Granted | 3,354,665 -
modified alginates for cell encapsulation and cell therapy
France | Granted | 3,354,665 -
modified alginates for cell encapsulation and cell therapy
Finland | Granted | 3,354,665 -
modified alginates for cell encapsulation and cell therapy
Greece | Granted | 3,354,665 -
modified alginates for cell encapsulation and cell therapy
Ireland | Granted | 3,354,665 -
modified alginates for cell encapsulation and cell therapy
Italy | Granted | 3,354,665 -
modified alginates for cell encapsulation and cell therapy
Netherlands | Granted | 3,354,665 -
modified alginates for cell encapsulation and cell therapy
Norway | Granted | 3,354,665 -
modified alginates for cell encapsulation and cell therapy
Spain | Granted | 3,354,665 -
modified alginates for cell encapsulation and cell therapy
Sweden | Granted | 3,354,665 -
modified alginates for cell encapsulation and cell therapy
Switzerland | Granted | 3,354,665 -
modified alginates for cell encapsulation and cell therapy
Turkey | Granted | 3,354,665 -
modified alginates for cell encapsulation and cell therapy
United Kingdom | Granted | 3,354,665 -
modified alginates for islet encapsulation and diabetes treatment
Belgium | Granted | 2,714,747 -
modified alginates for islet encapsulation and diabetes treatment
France | Granted | 2,714,747 -
modified alginates for islet encapsulation and diabetes treatment
Germany | Granted | 2,714,747 -
modified alginates for islet encapsulation and diabetes treatment
Ireland | Granted | 2,714,747 -
modified alginates for islet encapsulation and diabetes treatment
Netherlands | Granted | 2,714,747 -
modified alginates for islet encapsulation and diabetes treatment
Switzerland | Granted | 2,714,747 -
modified alginates for islet encapsulation and diabetes treatment
United Kingdom | Granted | 2,714,747 -
modified alginates for cell encapsulation and cell therapy
United States of America | Published application -
modified alginates for cell encapsulation and cell therapy
Germany | Granted | 3,354,665
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.